These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 29458729)

  • 1. Hypercoagulability and Vascular Disease.
    Taher AT; Cappellini MD; Bou-Fakhredin R; Coriu D; Musallam KM
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):237-245. PubMed ID: 29458729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis in thalassemia: why are we so concerned?
    Musallam KM; Taher AT
    Hemoglobin; 2011; 35(5-6):503-10. PubMed ID: 21910599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Complications and Their Management.
    Marcon A; Motta I; Taher AT; Cappellini MD
    Hematol Oncol Clin North Am; 2018 Apr; 32(2):223-236. PubMed ID: 29458728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Redefining thalassemia as a hypercoagulable state.
    Cappellini MD; Motta I; Musallam KM; Taher AT
    Ann N Y Acad Sci; 2010 Aug; 1202():231-6. PubMed ID: 20712798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The hypercoagulable state in thalassemia intermedia.
    Taher AT; Musallam KM; Inati A
    Hemoglobin; 2009; 33 Suppl 1():S160-9. PubMed ID: 20001621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Advances in pathogenesis and correlated clinical research of hypercoagulability in β thalassemia].
    Lv RY; Wen FQ; Yu J
    Zhongguo Dang Dai Er Ke Za Zhi; 2014 Jul; 16(7):774-8. PubMed ID: 25008893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalassemia and hypercoagulability.
    Taher AT; Otrock ZK; Uthman I; Cappellini MD
    Blood Rev; 2008 Sep; 22(5):283-92. PubMed ID: 18511163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model to study thrombotic complications of thalassemia.
    Kalish Y; Malyutin Z; Shai E; Dana M; Avraham L; Jahshan N; Rachmilewitz E; Fibach E; Varon D
    Thromb Res; 2015 Mar; 135(3):521-5. PubMed ID: 25613926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EASL Clinical Practice Guidelines: Vascular diseases of the liver.
    European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu
    J Hepatol; 2016 Jan; 64(1):179-202. PubMed ID: 26516032
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypercoagulability in β-thalassemia: a status quo.
    Cappellini MD; Poggiali E; Taher AT; Musallam KM
    Expert Rev Hematol; 2012 Oct; 5(5):505-11; quiz 512. PubMed ID: 23146054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thrombophilia and pregnancy. Prevention of maternal thrombotic and placental risks].
    Ann Med Interne (Paris); 2003; 154(5-6):422-30. PubMed ID: 15027600
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intermediate thalassemia: a new condition associated with hypercoagulability].
    Mannucci PM
    Ann Ital Med Int; 2000; 15(3):187-8. PubMed ID: 11059057
    [No Abstract]   [Full Text] [Related]  

  • 13. The caput medusae of hypercoagulability.
    Silver D; Vouyouka A
    J Vasc Surg; 2000 Feb; 31(2):396-405. PubMed ID: 10664508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of pulmonary thromboembolism in thalassemia intermedia: are these patients at risk for thrombotic events?
    Ciceri L; Amato M; Cappellini MD; Fiorelli G
    Ann Ital Med Int; 2000; 15(3):218-20. PubMed ID: 11059063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypercoagulability in renal transplant recipients. Identifying patients at risk of renal allograft thrombosis and evaluating strategies for prevention.
    Irish A
    Am J Cardiovasc Drugs; 2004; 4(3):139-49. PubMed ID: 15134466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Etiology and assessment of hypercoagulability with lessons from heparin-induced thrombocytopenia.
    Sniecinski RM; Hursting MJ; Paidas MJ; Levy JH
    Anesth Analg; 2011 Jan; 112(1):46-58. PubMed ID: 21081779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherothrombotic disorders: new insights from hematology.
    Andreotti F; Becker RC
    Circulation; 2005 Apr; 111(14):1855-63. PubMed ID: 15824214
    [No Abstract]   [Full Text] [Related]  

  • 18. Hypercoagulability syndromes.
    Thomas RH
    Arch Intern Med; 2001 Nov; 161(20):2433-9. PubMed ID: 11700155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient.
    Atichartakarn V; Chuncharunee S; Chandanamattha P; Likittanasombat K; Aryurachai K
    Blood; 2004 Apr; 103(7):2844-6. PubMed ID: 14645000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercoagulation and thrombophilia in nonalcoholic fatty liver disease: mechanisms, human evidence, therapeutic implications, and preventive implications.
    Northup PG; Argo CK; Shah N; Caldwell SH
    Semin Liver Dis; 2012 Feb; 32(1):39-48. PubMed ID: 22418887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.